A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

Schaller Martin and Kemény Lajos and Havlickova Blanka and Jackson Mark J. and Ambroziak Marcin and Lynde Charles and Gooderham Melinda and Remenyik Éva and Del Rosso James and Weglowska Jolanta and Chavda Rajeev and Kerrouche Nabil and Dirschka Thomas and Johnson Sandra: A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 82 (2). pp. 336-343. ISSN 0190-9622 (2020)

[thumbnail of 61-s2.0-S0190962219308679-main.pdf]
Preview
Text
61-s2.0-S0190962219308679-main.pdf - Published Version

Download (1MB) | Preview
Item Type: Article
Journal or Publication Title: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Date: 2020
Volume: 82
Number: 2
Page Range: pp. 336-343
ISSN: 0190-9622
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 30746290
DOI azonosító: https://doi.org/10.1016/j.jaad.2019.05.063
Date Deposited: 2020. Dec. 14. 15:16
Last Modified: 2020. Dec. 14. 15:16
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/20074
Web of Science® Times Cited: 21 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year